Epigenetic mechanisms in cardiovascular diseases

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Cardiovascular diseases (CVDs) are the leading cause of one-third of all deaths worldwide and accounting for an important burden of healthcare expenditure. CVD remains the number one cause of death and disability worldwide despite significant improvements in diagnosis, prevention, and early intervention efforts. Current scientific knowledge does not completely explain the complex pathophysiology underlying CVD, and therefore, a search for other pathways is constantly being conducted. Epigenetic regulation refers to changes in gene expression and ensuing phenotypes that occur independent of alterations in the DNA sequence per se, encompassing different levels of epigenetic modulation, including DNA methylation, posttranslational histone modifications, and long noncoding RNAs (lncRNAs). Epigenetic mechanisms have been shown to be associated with diverse human diseases such as cancer, CVD, autoimmune diseases, and Alzheimer disease. This chapter will thus focus on the role of epigenetics mechanisms in the area of cardiovascular risk.

Original languageEnglish (US)
Title of host publicationEpigenetics in Organ Specific Disorders
PublisherElsevier
Pages393-421
Number of pages29
ISBN (Electronic)9780128239315
ISBN (Print)9780128239322
DOIs
StatePublished - Jan 1 2022
Externally publishedYes

Keywords

  • Cardiovascular disease
  • DNA methylation
  • Epigenetics
  • Histone modification
  • lncRNA

ASJC Scopus subject areas

  • General Medicine
  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Epigenetic mechanisms in cardiovascular diseases'. Together they form a unique fingerprint.

Cite this